-->

Tech Seeker (TS)

Macrogenics Inc
Profile last edited on: 6/19/2013

Antibody-based therapies for autoimmune and infectious diseases and cancer
TS Type
Small Corporation
Status
Inactive
Year Founded
2000
Last Involved Year
2013

Key People / Management

Location Information

9640 Medical Center Drive
Rockville, MD 20850
   (301) 251-5172
   www.macrogenics.com

Public Profile

Macrogenics Inc is focused on exploiting the mechanisms by which cytotoxic antibodies mediate cell killing both for the development and improvement of existing therapeutic antibodies for the treatment of cancers and the development of therapeutics to prevent cytotoxic autoantibodies from triggering disease in autoimmunity. The firm is focused on product development derived from in-house and from in-licensed candidates in the areas of oncology, autoimmunity, antibody engineering and infectious disease. This multi-faceted approach in developing both antibodies and vaccines provides a diversified strategy for creating novel immunotherapeutics in areas of unmet medical need.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
USA
Employment
200
Revenue
N/A
Public/Private
Publicly Traded
Stock Info
NASDAQ : MGNX
Received SBIR $$
Yes

SBIR firms in the news

There are no news available.